Diamond Biofund Inc. (TPE:6901)
Taiwan
· Delayed Price · Currency is TWD 23.95
+0.85 (3.68%)
May 14, 2025, 12:42 PM CST
Diamond Biofund Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Other Revenue | -2,001 | -2,229 | -2,440 | 1,016 | 3,064 | 6,501 | Upgrade
|
| Revenue | -2,001 | -2,229 | -2,440 | 1,016 | 3,064 | 6,501 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | -66.85% | -52.88% | - | Upgrade
|
| Gross Profit | -2,001 | -2,229 | -2,440 | 1,016 | 3,064 | 6,501 | Upgrade
|
| Selling, General & Admin | 139.97 | 142.07 | 148.18 | 101.92 | 64.27 | 404.44 | Upgrade
|
| Operating Expenses | 168.55 | 170.65 | 158.03 | 113.39 | 76.13 | 404.44 | Upgrade
|
| Operating Income | -2,170 | -2,399 | -2,598 | 902.24 | 2,988 | 6,097 | Upgrade
|
| Interest Expense | -3.64 | -3.77 | -0.81 | -0.25 | -0.55 | -0.66 | Upgrade
|
| Interest & Investment Income | 22.17 | 15.15 | 16.24 | 0.86 | 0.12 | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | - | - | -4.88 | Upgrade
|
| Other Non Operating Income (Expenses) | -8.7 | -8.35 | -1.7 | -21.74 | -26.56 | - | Upgrade
|
| Pretax Income | -2,160 | -2,396 | -2,584 | 881.12 | 2,961 | 6,091 | Upgrade
|
| Income Tax Expense | 121.63 | 121.63 | -0.41 | 83.34 | 108.98 | 1.84 | Upgrade
|
| Net Income | -2,282 | -2,518 | -2,583 | 797.78 | 2,852 | 6,090 | Upgrade
|
| Net Income to Common | -2,282 | -2,518 | -2,583 | 797.78 | 2,852 | 6,090 | Upgrade
|
| Net Income Growth | - | - | - | -72.02% | -53.17% | - | Upgrade
|
| Shares Outstanding (Basic) | 851 | 850 | 779 | 749 | 804 | 674 | Upgrade
|
| Shares Outstanding (Diluted) | 851 | 850 | 779 | 770 | 809 | 685 | Upgrade
|
| Shares Change (YoY) | 5.86% | 9.19% | 1.21% | -4.90% | 18.16% | 1.55% | Upgrade
|
| EPS (Basic) | -2.68 | -2.96 | -3.32 | 1.06 | 3.55 | 9.03 | Upgrade
|
| EPS (Diluted) | -2.68 | -2.96 | -3.32 | 1.04 | 3.52 | 8.89 | Upgrade
|
| EPS Growth | - | - | - | -70.45% | -60.43% | - | Upgrade
|
| Free Cash Flow | 3,109 | 1,125 | -2,587 | 471.63 | -300.42 | -290.33 | Upgrade
|
| Free Cash Flow Per Share | 3.65 | 1.32 | -3.32 | 0.61 | -0.37 | -0.42 | Upgrade
|
| Dividend Per Share | - | - | - | 0.170 | 0.200 | 0.200 | Upgrade
|
| Dividend Growth | - | - | - | -15.33% | - | - | Upgrade
|
| Gross Margin | - | - | - | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | - | - | - | 88.84% | 97.52% | 93.78% | Upgrade
|
| Profit Margin | - | - | - | 78.55% | 93.08% | 93.67% | Upgrade
|
| Free Cash Flow Margin | - | - | - | 46.44% | -9.81% | -4.47% | Upgrade
|
| EBITDA | -2,162 | -2,393 | -2,597 | 903.57 | 2,990 | 6,099 | Upgrade
|
| EBITDA Margin | - | - | - | 88.97% | 97.59% | 93.82% | Upgrade
|
| D&A For EBITDA | 7.66 | 5.95 | 1 | 1.33 | 2.31 | 2.43 | Upgrade
|
| EBIT | -2,170 | -2,399 | -2,598 | 902.24 | 2,988 | 6,097 | Upgrade
|
| EBIT Margin | - | - | - | 88.84% | 97.52% | 93.78% | Upgrade
|
| Effective Tax Rate | - | - | - | 9.46% | 3.68% | 0.03% | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.